SUZHOU HIGHFINE BIOTECH CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 53.88 CNY | -1.14% |
|
+23.27% | -10.21% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 672M 92.97M | Sales 2025 * | 888M 123M | Capitalization | 5.82B 806M |
|---|---|---|---|---|---|
| Net income 2024 * | 194M 26.86M | Net income 2025 * | 257M 35.58M | EV / Sales 2024 * | 8.67 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 6.55 x |
| P/E ratio 2024 * |
29.9
x | P/E ratio 2025 * |
22.6
x | Employees | - |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 26.27% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.14% | ||
| 1 week | +23.27% | ||
| Current month | +23.27% | ||
| 1 month | +21.00% | ||
| 3 months | +28.04% | ||
| 6 months | -28.37% | ||
| Current year | -10.21% |
1 week
44.60
58.22
1 month
36.7158.22
Current year
36.5160.88
1 year
36.51118.88
3 years
36.51118.88
5 years
36.51118.88
10 years
36.51118.88
| Managers | Title | Age | Since |
|---|---|---|---|
Yong Zhu
CEO | Chief Executive Officer | 53 | 03-12-01 |
Xiao Yan Wang
DFI | Director of Finance/CFO | 44 | 04-01-31 |
Hao Yi Sun
CHM | Chairman | 46 | 11-06-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Qing Wang
BRD | Director/Board Member | 58 | 21-05-31 |
Yong Zhu
CEO | Chief Executive Officer | 53 | 03-12-01 |
Jie Xu
BRD | Director/Board Member | 45 | 04-10-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-09 | 53.88 | -1.14% | 6,595,095 |
| 24-05-08 | 54.5 | +3.89% | 7,223,424 |
| 24-05-07 | 52.46 | +0.02% | 9,282,508 |
| 24-05-06 | 52.45 | +20.00% | 5,801,816 |
End-of-day quote Shenzhen S.E., May 08, 2024
More quotes
Suzhou Highfine Biotech Co Ltd is a China-based company mainly engaged in the research and development (R&D), production and sales of Peptide synthesis reagents. The Company's main products include Peptide synthesis reagents such as condensation reagents, protection reagents and chiral racemic inhibition reagents, general-purpose molecular blocks and protein reagents.
Sector
Commodity Chemicals
Calendar
02:30am
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
53.88
Average target price
-
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -10.21% | 806M | |
| +6.75% | 105B | |
| -4.19% | 63.99B | |
| +51.90% | 43.02B | |
| +17.59% | 39.28B | |
| +6.89% | 33.09B | |
| +12.40% | 20.23B | |
| +16.25% | 17.39B | |
| +20.35% | 15.45B | |
| +9.86% | 15.07B |
- Stock Market
- Equities
- 301393 Stock